• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Health and Social Care Delivery Research

    Health and Social Care Delivery Research

    JournalISSN 2755-0079

    年发文量

    研究主题

    论文(237)

    排序
    1Individual Participant Data Meta-Analysis (IPDMA) of Long-Term COVID-19 Outcomes in a Systematic Review-Informed, International, Multidisciplinary Database
    Myzoon Ali, Marian C Brady,Pauline Campbell, Scott Rooney,Linda Williams,Lorna Paul,Helen Mason, Sarkis Manoukian, Charlie Chung, Mark Barber, Claire McGoldrick, Andrew Smith,

    Background:Identifying and addressing long-term health and societal challenges after COVID-19 is a research priority. Objectives:To create an international, multidisciplinary COVID-19 database, and synthesise long-term outcomes, predictors and costs. Design:Systematic identification of COVID-19 data sets and meta-analysis of individual participant data on long-term outcomes after COVID-19. Setting:Contributed data were collected in clinical, community and research settings. Interventions:Interventions from original studies were included as covariates in models. Data sources:MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, Web of Science, PsycInfo® (American Psychological Association, Washington, DC, USA), Cumulative Index to Nursing and Allied Health Literature, World Health Organization Global Index Medicus, Epistemonikos, LitCOVID; World Health Organization International Clinical Trials Registry Platform; ClinicalTrials.gov and supplementary searches for studies (November 2019-November 2021) were searched for studies on > 10 people from cohort, case-control, survey or randomised controlled trial studies, across any setting, describing validated assessment instruments, symptoms, hospitalisation, discharge destination or mortality beyond 28-days after COVID-19 onset. Data were extracted by two independent reviewers. Methods:Principal investigators contributed fully anonymised individual participant data. Demography, equity and symptoms were described. Assessment instruments were mapped to the International Classification of Functioning, Disability and Health. Factors associated with outcomes at 3-6 months, 9-12 months and beyond 12 months of index infection, for n > 500 individual participant data and > 1 data set were described using ratio of difference, point estimates, odds ratio and 95% confidence interval, as appropriate. The Mixed Methods Appraisal Tool described study quality; models were appraised using a Grading of Recommendations Assessment, Development and Evaluation-informed approach; heterogeneity was described using I2. Outcome measures:Included overall perception of health, multidomain cognitive function, anxiety, depression, stress, post-traumatic stress disorder, fatigue, strength, walking ability, mobility, coping with daily life, breathlessness, mortality, later hospitalisation and health-related quality of life. Results:PRECIOUS collated 116 data sets from 40 countries (individual participant data = 62,849), comprising 20 randomised controlled trials, 13 case-control, 60 cohort 2 longitudinal, 1 survey and 20 other study types. Participants' median age was 58 years interquartile range (45-68); 34,185 (54.4%) were female; 158 unique symptoms and 137 unique assessment instruments were captured, predominantly describing International Classification of Function, Disability and Health-body functions. Women had poorer outcomes across 30/37 models, compared with men. In 15/37 models, pre-existing lung disease and increasing age were associated with poorer outcomes; hospitalisation, diabetes and chronic kidney disease were each associated with poorer outcomes in 8/37 models. Initial hospitalisation resulted in lower health-related quality of life that did not recover for up to 2 years after initial infection. Heterogeneity was low in 34/37 models; 22/37 models were of moderate and 11/37 were of low quality. Limitations:Use of secondary data limits available covariates, outcomes and time points to those included in primary data sets; evidence was primarily based on high-income countries. There was a lack of data on longer-term healthcare resource use to estimate the costs to the healthcare system. Conclusions:PRECIOUS contributes to the overall picture of long-term COVID-19 outcomes beyond the long-COVID condition and highlights poorer long-term outcomes in women and people with pre-existing comorbidities. Future work:Evidence gaps included healthcare resource use, isolation, loneliness, societal participation and return to work outcomes. Data are needed on the role of health inequity on long-term outcomes. Study registration:This study is registered as PROSPERO (CRD42020224323, IRAS ID: 293578). Funding:This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: NIHR132895) and is published in full in Health and Social Care Delivery Research; Vol. 14, No. 29. See the NIHR Funding and Awards website for further award information.

    2026
    引用
    AI阅读
    加入学术空间
    2Extra Care Housing in the UK: a Scoping Review
    Sian de Bell,Zhivko Zhelev,Alison Bethel,Jo Thompson Coon,Rob Anderson

    Background:Extra care housing is a model of housing for older people where residents live in self-contained accommodation with flexible care and support available at all times. Ageing populations, seen globally and in the United Kingdom, mean increasing demand for this type of housing. While extra care housing may help people live longer independently, its provision poses challenges (e.g. resourcing flexible care). By identifying existing evidence, this scoping review will inform future research into extra care housing, to support the development of schemes that meet the needs of older people. Objectives:To identify the volume, focus/questions, study design, quality and main findings of empirical research and evaluations relating to extra care housing in the United Kingdom. Methods:We conducted a scoping review of evidence syntheses and primary research. Applied Social Sciences Index and Abstracts, Cumulated Index in Nursing and Allied Health Literature, MEDLINE, Health Management Information Consortium, ProQuest Dissertations and Theses Global, Social Policy and Practice (SPP) and Web of Science, along with relevant websites, were searched for studies (June 2024). We also completed citation-chasing on included studies. We included systematic reviews and empirical evaluations published since 2010, conducted in the United Kingdom, focused on extra care housing for older people, and investigating any outcome. Data were tabulated and summarised narratively. Critical appraisal was conducted using the Mixed Methods Appraisal Tool checklist (primary studies) or A MeaSurement Tool to Assess systematic Reviews 2 (systematic reviews). Consultation with stakeholders and extra care housing residents informed the review. Results:Ninety-eight publications were included. Thirty-seven were qualitative, 28 were quantitative, 19 took a mixed-method approach and 2 were modelling studies using secondary data. Older people were participants in 57 studies. Many studies provided limited information on the characteristics of participants and the included extra care housing schemes. Included studies had three overlapping areas of focus: (1) the supply of extra care housing and older people's decision-making regarding relocation; (2) living in extra care housing (e.g. impact on quality of life, residents' experiences of community, physical infrastructure); and (3) leaving extra care housing (there was little research in this area). While much of the available research supports the provision of extra care housing as a model of housing with care for older people, studies were variable in their methodological quality and reporting. Consultation with extra care housing residents raised topics that corresponded with the findings of included studies (e.g. the importance of care provision in supporting independence). Limitations:Extra care housing is known by different names (e.g. assisted living). This created challenges in finding studies and understanding whether the housing model being studied met our definition of extra care housing. As we took an inclusive approach, some included studies may have focused on other types of housing with care. Conclusions:There is a growing body of evidence regarding the provision of extra care housing as a model of housing for older people. However, given the changing health and social care landscape and increasing care needs of the population, further research is needed to support the future development of extra care housing. Future work:High-quality research on effectiveness and cost-effectiveness is needed, as well as on specific topics (e.g. whether extra care housing can be a home for life). Study registration:The protocol was published on Zenodo (https://doi.org/10.5281/zenodo.12698241). Funding:This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: NIHR174287) and is published in full in Health and Social Care Delivery Research; Vol. 14, No. 26. See the NIHR Funding and Awards website for further award information.

    2026
    引用
    AI阅读
    加入学术空间
    3Exploring and Improving Resuscitation Decisions in out of Hospital Cardiac Arrest: Synopsis of the PROTECTeD Mixed-Method Study
    Michael A Smyth, Terry P Brown,Rachael Fothergill,Frances Griffiths,Ranjit Lall,John Long,Stavros Petrou, Aloysius Niroshan Siriwardena,Anne-Marie Slowther, Lauren Betteley,Karin Eli, Galina Gardiner,

    Background:The PROTECTeD study sought to develop an evidence-based termination of resuscitation guideline for use within United Kingdom ambulance services. Methods:This mixed-methods study comprised several work packages: Work package 1 - diagnostic test accuracy meta-analysis of termination of resuscitation rules Work package 2 - modelling performance of termination of resuscitation rules using data from the Out of Hospital Cardiac Arrest Outcomes registry Work package 3 - review of ambulance service practices Work package 4 - qualitative interviews with ambulance clinicians, emergency department clinicians and relatives of non-survivors Work package 5 - stakeholder consensus conference to develop a new termination of resuscitation guideline. Results:We described the performance of 42 different termination of resuscitation rules. Our meta-analysis suggests the best performing termination of resuscitation rule is the Universal termination of resuscitation. We modelled the performance of 29 termination of resuscitation rules and found that none would be suitable for implementation within a United Kingdom context. We identified significant variation in how the termination of resuscitation guideline was implemented across the United Kingdom (UK) ambulance services. Ambulance clinicians experience conflict between what the guideline permits them to do and being able to act in the patient's best interest. They felt obliged to follow the guideline. Most emergency department staff believed that paramedics should be empowered to stop resuscitation where appropriate. However, some felt that more senior emergency department clinicians should make these decisions. Relatives needed to be informed about the resuscitation attempt and must feel confident that every effort had been made to save their relative. They also believed that they were able to provide useful information to inform paramedic decision-making. We drafted a new termination of resuscitation guideline in conjunction with clinical experts and multiple stakeholders at a consensus conference. We employed nominal group techniques to determine content and formulate treatment recommendations. Discussion:Termination of resuscitation decisions are complex, requiring consideration of several important aspects, including what is in the patient's best interest. Our work suggests that the current ambulance guideline may restrict the paramedics ability to act in the patient's best interest, increasing the potential for moral injury. Conclusion:Paramedic decision-making is informed by both clinical and best interest considerations. Relatives are confident that paramedics do everything possible to save their loved one, and they are able to provide paramedics with information to guide decision-making. We developed a new evidence-based termination of resuscitation guideline, employing nominal group techniques, in collaboration with multiple stakeholders. Limitations:The evidence comprises observational studies that must be interpreted with caution. We captured the views of multiple stakeholders and patients with personal experience of cardiac arrest. Their insights may not be representative of the wider population who have not had the same experience. Future work:Future research should encompass alternative predictors of poor outcome (e.g. clinical frailty) as well as technology (e.g. ultrasound) to enhance decision-making. Better understanding of how cardiac arrest transport decisions impact system performance and crew safety would be helpful. Little is known about paramedic decision-making in relation to unfavourable neurological outcome rather than fatal outcome. Paramedics may benefit from a decision-making framework. Funding:This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme as award number 17/99/34.

    2026
    引用
    AI阅读
    加入学术空间
    4Evaluating the Implementation of Electronic Palliative Care Co-ordination Systems (epaccs) and Optimising Future Service Provision for Palliative and End-of-life Care: a Synopsis of the Optimal Care Mixed-Method Study
    Matthew J Allsop,Jacqueline Birtwistle,Andy Bradshaw,Paul Carder, Catherine J Evans,Robbie Foy, Barbara Hibbert,Pablo Millares Martin, Sam Relton, Suzanne Richards,Katherine E Sleeman,Maureen Twiddy,

    Background:Electronic Palliative Care Co-ordination Systems are central to end-of-life care policy despite critical gaps in the evidence base underpinning their use. It is unclear how Electronic Palliative Care Co-ordination Systems are being implemented across England and there is a lack of research to understand their use in routine care. Aim:To understand how Electronic Palliative Care Co-ordination Systems are currently being used in routine care and to guide the development of interventions to support their optimal implementation and maximise patient benefit. Method:A mixed-method approach was adopted across the five-stage programme of research. Packages of work included: (1) a national online survey of end-of-life care leads at clinical commissioning groups in England; (2) an online survey of community and hospital-based health and care professionals in West Yorkshire and London; (3) semistructured interviews with a sample of survey respondents; (4) focus groups and interviews with patients with progressive chronic illnesses and carers and (5) regional and national Theory of Change workshops. Results:Two-thirds of surveyed regions have Electronic Palliative Care Co-ordination Systems in place. Where present, there is limited use of Electronic Palliative Care Co-ordination Systems to document patients' wishes and preferences. Low uptake may be explained by challenges experienced by health professionals. This includes limited interoperability across electronic health record systems in which Electronic Palliative Care Co-ordination Systems are typically nested, affecting information sharing across settings. Uncertainty was common across health and care professionals relating to what Electronic Palliative Care Co-ordination Systems are, who they are for and how organisations should monitor them. Mid-range programme theory was generated to guide the development and evaluation of Electronic Palliative Care Co-ordination Systems alongside recommendations for decision-makers and commissioners for palliative and end-of-life care in England. Limitations:The project was conducted across England with in-depth health and care professional engagement in two regions of England. This may limit the applicability of findings across England, although the project included large regions with multiple Electronic Palliative Care Coordination Systems operating at different levels of maturity. Conclusions:Electronic Palliative Care Co-ordination Systems are not working as intended for palliative and end-of-life care delivery in England. The application of the recommendations generated through this project can ensure consideration of the wider ecosystem in which Electronic Palliative Care Co-ordination Systems are being implemented, guiding system development that promotes health and care professional engagement and facilitates patient and carer access to Electronic Palliative Care Co-ordination Systems records. Future work:Future research is required to develop approaches that seek to improve health professional engagement with digital approaches to advance care planning documentation and sharing. Furthermore, there is a need to develop and evaluate patient and carer access to digital advance care planning records. Lastly, the mid-range programme theory generated through this project requires continued refinement and use to evaluate Electronic Palliative Care Co-ordination Systems' implementation. Funding:This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme as award number NIHR129171.

    2026
    引用
    AI阅读
    加入学术空间
    5Improving Medicines Use in People with Polypharmacy in Primary Care: a Synopsis from the IMPPP Cluster-Rct with Pilot-Feasibility Study
    Rupert A Payne, Ammar Annaw,Peter S Blair,Barbara Caddick, Carolyn A Chew-Graham,Tobias Dreischulte, Lorna J Duncan,Bruce Guthrie, Nouf Jeynes,Cindy Mann, RoxanneM Parslow,Jeff Round,

    Background:Polypharmacy is a major challenge for patient safety and effective resource use. High-quality evidence supporting polypharmacy management is lacking. Aim:To develop, optimise and evaluate a primary care complex intervention for reducing medically defined potentially inappropriate prescribing among patients experiencing polypharmacy. Methods:Phase 1: Qualitative interviews and focus groups with patients and professionals explored views/experiences of existing National Health Service Scotland interventions, informing development of core intervention components. Phase 2: An external pilot-feasibility study was conducted in five general practitioner practices to optimise the Improving Medicines use in People with Polypharmacy in Primary care intervention. A formative mixed-methods process evaluation examined intervention implementation, alongside evaluating trial processes and collecting data to inform phase 3. Phase 3: A pragmatic, open-label two-arm parallel cluster-randomised trial was conducted in English general practice. The intervention (19 practices) comprised a structured, collaborative and patient-centred approach to medication review, supported by informatics, clinician training, performance feedback and financial incentivisation. The comparator was usual care (18 practices). Up to 50 adults receiving ≥ 5 regular medications, with ≥ 1 indicator of potentially inappropriate prescribing, were reviewed per practice over 6 months. Primary outcome was number of potentially inappropriate prescribing indicators at 26-week follow-up. Secondary outcomes included patient-reported measures and service use. Cost-effectiveness and cost-utility analyses were conducted (primary economic outcome quality-adjusted life-years). A mixed-methods process evaluation (patient surveys, patient/clinician interviews, audio-recorded observations) explored implementation. Results:Phase 1: Intervention component design was informed by findings related to elements of the medication review, informatics and clinician training. Phase 2: Core intervention elements were successfully implemented in the pilot, although clinical delivery was hampered by disruptions due to the coronavirus disease pandemic. Phase 3: Participants were recruited between January and June 2022 (intervention N = 891, usual care N = 836), median age 73 years, 49% female, with median four long-term conditions and eight medications. No improvement in the primary outcome was observed (mean difference potentially inappropriate prescribing count - 0.007; 95% confidence interval -0.21 to 0.199). Treatment burden was slightly improved, and subgroup analysis suggested potential improvements in less complex patients. The process evaluation found general practitioners and pharmacists valued and benefitted from the model of interprofessional collaboration, which strengthened working relationships and provided an opportunity for knowledge sharing and joint decision-making that supported management of clinical uncertainty. Most patients (73.2%) reported satisfaction with the review, with satisfaction strongly associated with perceptions of shared decision-making. There was no evidence of cost-effectiveness, although the economic evaluation did not quantify the aforementioned benefits or other broader factors of potential interest to decision-makers. Limitations:Key limitations include concurrent changes in usual care, potentially insensitive outcome measures and limited study-population generalisability. Interpretation:A complex medication optimisation intervention did not reduce potentially inappropriate prescribing in patients with polypharmacy. Findings strongly support revisiting current medication optimisation policy, with one-off structured reviews, even when enhanced with digital healthcare solutions and clinical pharmacy investment, not guaranteed to improve key clinical outcomes. Nevertheless, the positive patient and clinician findings are important: protected time for interprofessional collaborative working, plus effective integration of shared decision-making within patient-facing reviews, may facilitate improved patient care more broadly. Future work:Research should develop new patient-centred outcomes and identify higher-risk patients. Funding:This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme as award number 16/118/14.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 237 篇论文

    高被引作者

    作者引用发文
    Sidhu Manbinder S1187
    Cecilia Vindrola-Padros935
    Sonila Tomini775
    ‪Stephen Morris7510
    Jo Ellins743
    Chris Sherlaw-Johnson707
    Naomi Fulop633
    Georghiou Theo633
    Kelly E Singh601
    Jon Sussex417

    高产作者

    作者引用发文
    Geoff Wong1412
    ‪Stephen Morris7510
    a ramsay209
    Andrew Booth108
    Pei Li Ng157
    Jon Sussex417
    Sidhu Manbinder S1187
    Chris Sherlaw-Johnson707
    Heather Gage236
    Penny Bee136

    相关期刊

    Health & social care in the community
    Rural and remote health
    Family medicine and community health
    BMC Health Services Research
    Primary health care research & development
    Health Services and Delivery Research
    BMC Primary Care